Abstract
This article reviews regional lymph node assessment in lung cancer. In the absence of a distant metastasis, the absence or location of lung cancer spread to a regional mediastinal lymph node affects treatment options and prognosis. Regional lymph node maps have been created to standardize assessment of the N descriptor. The International Association for the Study of Lung Cancer lymph node map is used for the standardization of N descriptor assessment. CT, PET/CT with fluorodeoxyglucose, endobronchial ultrasound–guided and/or esophageal ultrasound–guided biopsy, and mediastinoscopy are common modalities used to determine the N descriptor.
Original language | English (US) |
---|---|
Pages (from-to) | 399-409 |
Number of pages | 11 |
Journal | Radiologic Clinics of North America |
Volume | 56 |
Issue number | 3 |
DOIs | |
State | Published - May 2018 |
Keywords
- International association for the study of lung cancer (IASLC)
- Lung cancer
- Lymph node
- Lymph node map
- Staging
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging